Daily Stock Analysis, ACWI, Acura Pharmaceuticals Inc, priceseries

Acura Pharmaceuticals Inc. Daily Stock Analysis
Stock Information
Open
60.54
Close
60.70
High
60.74
Low
60.52
Previous Close
60.54
Daily Price Gain
0.16
YTD High
60.74
YTD High Date
Jan 13, 2017
YTD Low
59.35
YTD Low Date
Jan 3, 2017
YTD Price Change
1.07
YTD Gain
1.79%
52 Week High
60.74
52 Week High Date
Jan 13, 2017
52 Week Low
47.96
52 Week Low Date
Feb 11, 2016
52 Week Price Change
9.59
52 Week Gain
18.77%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Oct 2. 2015
53.09
Nov 6. 2015
56.08
25 Trading Days
5.63%
Link
Company Information
Stock Symbol
ACWI
Exchange
NasdaqCM
Company URL
http://www.acurapharm.com
Company Phone
847-705-7709
CEO
Robert B. Jones
Headquarters
Illinois
Business Address
616 N. NORTH COURT, SUITE 120, PALATINE, IL 60067
Sector
Equity
Industry Category
Drugs
Industry Group
Drug Delivery
CIK
0000786947
About

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, researches, develops, and commercializes products to address medication abuse and misuse.

Description

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, researches, develops, and commercializes products to address medication abuse and misuse. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional opioid products in various stages of formulation development. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc.; Egalet Ltd.; and Egalet Corporation to manufacture and commercialize Oxaydo products worldwide. The company was founded in 1935 and is based in Palatine, Illinois.